Last reviewed · How we verify
NCT06741514
A Study of Precice Intramedullary Limb Lengthening System (IMLL) Limb Lengthening Procedures
trial testing Precice IMLL in Limb Length Discrepancy in 100 participants. Enrolling by invitation.
1 July 2026
Quick facts
| Lead sponsor | NuVasive |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 25 March 2024 |
| Primary completion | 1 July 2026 |
| Estimated completion | 30 December 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Precice IMLL
Conditions studied
- Limb Length Discrepancy — all drugs for Limb Length Discrepancy →
Sponsor
NuVasive — full company profile →
Who can join
Eligibility, any sex, with Limb Length Discrepancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Sponsor is conducting a survey to understand how parents or legal guardians feel about the benefits of using the Precice IMLL System to lengthen limbs in children who are 12 years old or younger.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06741514
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other NuVasive trials
Trials by the same sponsor.
- NCT05691231 — Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels · enrolling by invitation
- NCT05566704 — Retrospective Modulus ALIF Study · completed
- NCT05066711 — NuVasive® ACP System Study · enrolling by invitation
- NCT04980378 — Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc · completed
- NCT04689880 — XLIF Decade Plate System Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06741514 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NuVasive
- Last refreshed: 18 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06741514.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing